Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity

Fresia Pareja(Memorial Sloan Kettering Cancer Center), Edi Brogi(Memorial Sloan Kettering Cancer Center), Achim A. Jungbluth(Gynecologic Oncology Group), Melinda E. Sanders(Vanderbilt University), Syed A. Hoda(NewYork–Presbyterian Hospital), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Juan Palazzo(Thomas Jefferson University), Laura C. Collins(Beth Israel Deaconess Medical Center), Rohit Bhargava(Magee-Womens Hospital), Denise Frosina(Memorial Sloan Kettering Cancer Center), Fatemeh Derakhshan(BC Cancer Agency), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Edaise M. da Silva(Memorial Sloan Kettering Cancer Center), Timothy M. D’Alfonso(Northwell Health), Yunn‐Yi Chen(University of Vermont), Felipe C. Geyer(Memorial Sloan Kettering Cancer Center), John R. Lozada(Twin Cities Orthopedics), Arnaud Da Cruz Paula(Memorial Sloan Kettering Cancer Center), Hannah Y. Wen(Memorial Sloan Kettering Cancer Center), Jorge S. Reis‐Filho(AstraZeneca (France)), Thais Basili(Memorial Sloan Kettering Cancer Center), Gregor Krings(Cleveland Clinic), Dilip D. Giri(Memorial Sloan Kettering Cancer Center), Elaine Zhong(Northwell Health), Malcolm Hayes(University of British Columbia), Stuart J. Schnitt(Brigham and Women's Hospital)
Modern Pathology
January 2, 2020
Cited by 60


Related Papers